Puma Biotech posts Q2 2026 financial results presentation webcast report - PBYI News | RalliesPuma Biotech posts Q2 2026 financial results presentation webcast report
P
PBYI• Q2 2026 webcast highlights
- Puma Biotechnology webcast on Q2 2026 financial results showed NERLYNX net revenue of USD 53.6 million.
- Net revenue rose about 9% from Q2 2025, up about 28% from Q1 2026.
- Inventory change was -USD 1 million in Q2 2026 versus -USD 1.3 million in Q2 2025.
- Ex-factory bottles sold totaled 2,929, up about 12% from Q2 2025, up about 26% from Q1 2026.
- U.S. commercial demand reached 2,986 bottles, up about 11% from Q2 2025, up about 8% from Q1 2026.
•
